Biocon Q4FY25 results: Net profit jumps 153% YoY to Rs 344 crore; revenue rises 12% to Rs 4,454 crore
By News Desk Published on May 8, 2025, 19:50 IST
Biocon Limited reported a strong financial performance for the quarter and financial year ended March 31, 2025. For Q4FY25, consolidated revenue came in at Rs 4,454 crore, marking a 12% year-on-year (YoY) increase. On a like-for-like basis, the revenue grew 15% YoY after adjusting for revenues from Branded Formulations India (BFI).
EBITDA rose 16% YoY to Rs 1,115 crore with an EBITDA margin of 25%. Core EBITDA, excluding R&D and other adjustments, came in at Rs 1,363 crore with a margin of 31%.
The company posted a net profit of Rs 344 crore in Q4FY25, a significant 153% YoY jump. On a like-for-like basis, the net profit rose 162% YoY. Profit before tax (PBT) surged 53% YoY to Rs 487 crore. Segmental performance Generics : Revenue rose 46% YoY to Rs 1,048 crore, driven by strong contributions from Lenalidomide and Dasatinib launches in the U.S.
: Revenue rose 46% YoY to Rs 1,048 crore, driven by strong contributions from Lenalidomide and Dasatinib launches in the U.S. Biosimilars : Revenue increased 4% YoY to Rs 2,463 crore. On an adjusted basis, it rose 9% YoY.
: Revenue increased 4% YoY to Rs 2,463 crore. On an adjusted basis, it rose 9% YoY. Research Services (Syngene): Revenue climbed 11% YoY to Rs 1,018 crore. Full-year FY25 highlights
For the full year, Biocon reported: Total revenue : Rs 16,470 crore, up 5% YoY (8% like-for-like)
: Rs 16,470 crore, up 5% YoY (8% like-for-like) EBITDA : Rs 4,374 crore, up 5% YoY
: Rs 4,374 crore, up 5% YoY Net profit: Rs 1,013 crore, down 1% YoY; however, like-for-like net profit increased 30% Dividend and capital plans
The Board recommended a final dividend of Rs 0.50 per share. Additionally, it approved raising up to Rs 4,500 crore through various financial instruments for debt repayment and strategic investments. Strategic developments
Biocon Biologics launched its fifth biosimilar, Yesintek (bUstekinumab), in the U.S. and Germany, and secured a U.S. market entry for Yesafili (bAflibercept). The company also partnered with Civica Inc. to increase access to insulins.
Syngene crossed Rs 1,000 crore in quarterly revenue for the first time and acquired a biologics manufacturing facility in the U.S., expanding its CDMO capabilities.
Biocon has also initiated an evaluation of a potential merger between Biocon Limited and Biocon Biologics. Sustainability
Biocon and Biocon Biologics were both included in the S&P Global Sustainability Yearbook 2025, with Biocon ranked among the top 5% in the Biotechnology sector.
News desk at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 hours ago
- Business Upturn
Solar Industries shares in focus as defence arm secures 450 Nagastra-1R loitering munitions order from Indian Army
Solar Industries shares were in focus today after the company's defence subsidiary received an order for 450 units of Nagastra-1R loitering munitions from the Indian Army. As of 11:45 AM, the shares were trading 0.35% higher at Rs 17,056.00. BIG NEWS FOR SOLAR INDUSTRIES SOLAR IND: DEFENCE ARM GETS 450 NAGASTRA-1R LOITERING MUNITIONS ORDER FROM INDIAN ARMY — RedboxGlobal India (@REDBOXINDIA) June 23, 2025 The stock opened at ₹17,050.00 and climbed to a high of ₹17,164.00 during intraday trade, edging closer to its 52-week high of ₹17,300.00. The day's low was ₹16,910.00. The development has sparked renewed interest in the stock, which has already seen a strong rally over the past year, rising from a 52-week low of ₹8,482.50. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
2 hours ago
- Business Upturn
ideaForge secures Rs 137 crore defence order from Ministry of Defence to supply Mini UAVs
By Aditya Bhagchandani Published on June 23, 2025, 11:48 IST ideaForge Technology Limited announced on June 23 that it has received a significant order worth approximately Rs 137 crore from the Ministry of Defence for the supply of Mini Unmanned Aerial Vehicles (UAVs) along with accessories. The order is expected to be executed within a 12-month period. According to the company's regulatory filing, the contract is domestic in nature and does not fall under related-party transactions. It also clarified that no promoter or promoter group entities have any interest in the awarding body. The order involves a complete supply of Mini UAVs and associated accessories, marking another major step forward for ideaForge's contribution to India's defence capabilities. ideaForge, headquartered in Navi Mumbai, is known for its indigenous drone manufacturing and has previously supplied UAVs for various strategic and surveillance applications. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
4 hours ago
- Business Upturn
Confidence Futuristic Energetech secures Rs 32.45 crore order from BPCL for cascade supply
By Aditya Bhagchandani Published on June 23, 2025, 11:01 IST Shares of Confidence Futuristic Energetech secures Rs 32.45 crore order from BPCL for cascade supply Energetech may be in focus after the company announced that its 100% subsidiary, Confidence Enterprise Pvt Ltd, has secured a major order worth approximately Rs 32.45 crore from Bharat Petroleum Corporation Limited (BPCL). The order pertains to the supply of various sizes of cascades, with deliveries scheduled within 10 weeks from the date of call-off or site purchase order. The company disclosed this update under Regulation 30 of the SEBI (LODR) Regulations, stating that the deal does not fall under related-party transactions and that the promoter group holds no interest in the contracting entity. This development reflects continued momentum for Confidence Futuristic in the energy and gas equipment sector and is expected to boost operational revenues in the near term. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
